Breast tumor localization
Tuflex
SOMATEX launches new breast localization system on US market
Tuflex can stay in place overnight and uncouples the marking from the excision procedure. Tuflex can help in avoiding scheduling conflicts, particularly with early morning surgeries.
Our products
Our news
14.1.2021
Tumark® Vision: Highest detection rate in SenTa-Study
News
…
5.1.2021
SOMATEX® is now part of Hologic!
News
…
15.12.2020
Product Manager (m/w/d)
Job ad
…
03.12.2020
New: SurgLite with 4 hours runtime!
News
…
17.11.2020
Long awaited results of SenTa trial published!
News
…
16.10.2020
Technical product manager medical devices (m/w/d)
Job ad
…
Our products in clinical use
Short video clips show everyday clinical practice in the breast center of the Evang. Kliniken Essen-Mitte in Essen, Germany. In action: our Tumark Vision, Duo System, Somacore Verify and Core Biopsy Needle. Watch these videos about wire marking, breast biopsy and marking of breast lesions here.
At SOMATEX, we develop products that exceed the standard. To do this, we are closely collaborating with doctors and specialists in the medical fields in order to transfer their requirements into innovative product solutions. As a medtech company we have become experts for breast tumor localization, worldwide.
Nils Drewes, General Sales Director
Tumark® Vision Atlas
Case studies
The Tumark Vision Atlas contains case studies of the Tumark Vision biopsy site marker and provides clinical information. The long-term visibility of a biopsy site marker is particularly important in neoadjuvant chemotherapy. Some of the following case studies report this application scenario.